| Dr James Frederick Kirk, MD | |
|
3612 23rd St, Lubbock, TX 79410-1326 | |
| (806) 793-8787 | |
| (806) 793-0150 |
| Full Name | Dr James Frederick Kirk |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 48 Years |
| Location | 3612 23rd St, Lubbock, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033117155 | NPI | - | NPPES |
| 116856104 | Other | TX | FIRSTCARE |
| 132893209 | Medicaid | TX | |
| 345836YKT8 | Other | TX | MEDICARE |
| U82223 | Medicaid | NM | |
| 8EF229 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | E6118 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Covenant Medical Center | Lubbock, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Covenant Medical Group | 6901889393 | 218 |
News Archive
When medical residents work shorter hours, fewer patients are transferred to intensive care and there are not as many interventions by pharmacists to avoid errors in medication, according to a Yale School of Medicine study in Annals of Internal Medicine.
Although diffuse large B-cell lymphoma (DLBCL) is a curable disease in most patients aged 65 years or older, these patients are also at higher risk of chemotherapy-related death within the first 30 days of treatment.
As part of its I.V. Room of the Future initiative to cooperate with other industry leaders, Health Robotics today announced the immediate availability of its revolutionary Virtual High-Availability Architecture (up to 99.99%), including state-of-the-art, virtualization compliant, cluster and fail-over, disaster recovery, and back-up solutions for its CytoCare and i.v.STATION robots [with future expansion to TPNstation when available], and its i.v.SOFT Workflow Engine for manual compounding.
NewLink Genetics Corporation announces launching of an open-label, randomized, multi-institutional Phase 3 study in patients with borderline resectable or locally advanced unresectable pancreatic cancer.
› Verified 4 days ago
| Entity Name | Covenant Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376598904 PECOS PAC ID: 6901889393 Enrollment ID: O20040608000563 |
News Archive
When medical residents work shorter hours, fewer patients are transferred to intensive care and there are not as many interventions by pharmacists to avoid errors in medication, according to a Yale School of Medicine study in Annals of Internal Medicine.
Although diffuse large B-cell lymphoma (DLBCL) is a curable disease in most patients aged 65 years or older, these patients are also at higher risk of chemotherapy-related death within the first 30 days of treatment.
As part of its I.V. Room of the Future initiative to cooperate with other industry leaders, Health Robotics today announced the immediate availability of its revolutionary Virtual High-Availability Architecture (up to 99.99%), including state-of-the-art, virtualization compliant, cluster and fail-over, disaster recovery, and back-up solutions for its CytoCare and i.v.STATION robots [with future expansion to TPNstation when available], and its i.v.SOFT Workflow Engine for manual compounding.
NewLink Genetics Corporation announces launching of an open-label, randomized, multi-institutional Phase 3 study in patients with borderline resectable or locally advanced unresectable pancreatic cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Frederick Kirk, MD 2215 Nashville Ave, Lubbock, TX 79410-1105 Ph: (806) 725-5844 | Dr James Frederick Kirk, MD 3612 23rd St, Lubbock, TX 79410-1326 Ph: (806) 793-8787 |
News Archive
When medical residents work shorter hours, fewer patients are transferred to intensive care and there are not as many interventions by pharmacists to avoid errors in medication, according to a Yale School of Medicine study in Annals of Internal Medicine.
Although diffuse large B-cell lymphoma (DLBCL) is a curable disease in most patients aged 65 years or older, these patients are also at higher risk of chemotherapy-related death within the first 30 days of treatment.
As part of its I.V. Room of the Future initiative to cooperate with other industry leaders, Health Robotics today announced the immediate availability of its revolutionary Virtual High-Availability Architecture (up to 99.99%), including state-of-the-art, virtualization compliant, cluster and fail-over, disaster recovery, and back-up solutions for its CytoCare and i.v.STATION robots [with future expansion to TPNstation when available], and its i.v.SOFT Workflow Engine for manual compounding.
NewLink Genetics Corporation announces launching of an open-label, randomized, multi-institutional Phase 3 study in patients with borderline resectable or locally advanced unresectable pancreatic cancer.
› Verified 4 days ago
Dr. Thomas Nelius, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 3502 9th St, Suite 260, Lubbock, TX 79415 Phone: 806-743-1810 Fax: 806-743-1335 | |
Chris H Brown, PA-C Urology Medicare: Accepting Medicare Assignments Practice Location: 6102 82nd St, Suite 5, Lubbock, TX 79424 Phone: 806-771-0077 Fax: 806-771-3175 | |
Carl Lee Britton Jr., M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 418 N Utica Ave, Lubbock, TX 79416 Phone: 806-771-5882 Fax: 806-687-9002 | |
Obie Lee Stalcup, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 4515 Marsha Sharp Fwy, Lubbock, TX 79407 Phone: 806-744-7223 Fax: 806-740-3325 | |
Miss Jonathan S. Vordermark, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 3502 9th St, Suite 260, Lubbock, TX 79415 Phone: 806-743-1810 Fax: 806-743-1335 | |
Dr. Michael R Crone, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 3601 4th St Stop 7260, Lubbock, TX 79430 Phone: 806-743-1810 Fax: 806-743-1335 |